Defining and Striving for HBV Cure: What’s in the Pipeline

In this episode,  Carla S. Coffin, MD, MSc, shares her thoughts on the different investigational approaches under evaluation for their potential to achieve HBV cure, including entry inhibitors, capsid inhibitors, siRNAs, immune modulators, TLR agonists, therapeutic vaccines, and checkpoint inhibitors.Presenter:Carla S. Coffin, MD, MScProfessor of MedicineDivision of Gastroenterology and HepatologyDepartment of MedicineUniversity of CalgaryMedical Director of Calgary Liver UnitDivision of Gastroenterology and HepatologyDepartment of MedicineFoothills Medical CentreCalgary, Alberta, CanadaContent based on an online CME program supported by independent educational grants from AbbVie and Gilead Sciences, Inc. and developed in collaboration with the American Liver Foundation. Link to full program:https://bit.ly/3OGHvOv Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

There are no comments yet.

Please log in to write the first comment.